טוען...
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir
PURPOSE: People chronically infected with hepatitis C virus (HCV) have diminished patient-reported outcomes (PROs). This study aimed to compare the impact of elbasvir/grazoprevir (EBR/GZR) treatment versus sofosbuvir with pegylated interferon and ribavirin (SOF/PR) on changes in PROs: 1) during the...
שמור ב:
| הוצא לאור ב: | Patient Prefer Adherence |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6294167/ https://ncbi.nlm.nih.gov/pubmed/30587935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S172732 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|